Vanessa Carle, Secretary at Lexaria Bioscience Corp. (LEXX), bought 750 shares at $0.91 ($683) on 2025-07-29, disclosed to the SEC on 2025-07-30.
Open-market purchase of $682 LEXX by Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.